glp-1 amgen Study predicts 16 new obesity drugs may come to market Amgen (AMGN) Expands Obesity Strategy

Undeclared active substances Products that are frequently marketed as natural actually contain pharmacologically active substances without any declaration or dosage information

In particular, Frssing et al

Gut 69 (8), 14231431

As a next-generation triple-action peptide, it works by targeting GLP-1, GIP, and glucagon receptors togetherthree critical pathways in metabolism

Popular blood pressure medication recalled nationwide: FDA "Sure, it's going to improve her power-to-weight ratio," Michaels said, "but that simply means she'll move quicker, she'll be a little more agile, because she's significantly lighter." She continued, saying GLP-1s are not a performance enhancer like stimulants or steroids, and it doesn't improve fitness methods directly

SOURCE BodySpec